Search Press releases Keywords From To 23 Sep 2024 UCB announces U.S. FDA approvals for BIMZELX[®] (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis Read More 9 Sep 2024 New insights highlight unmet needs for people living with Lennox-Gastaut syndrome and significant burden of the disease Read More 6 Sep 2024 Transparency notification BlackRock, Inc. Read More 6 Sep 2024 UCB presents new data across expansive epilepsies portfolio at 15th European Epilepsy Congress (EEC) Read More 5 Sep 2024 Transparency notification BlackRock, Inc. Read More 5 Sep 2024 Transparency notification BlackRock, Inc. Read More Pagination First page Previous page Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Page 9 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
